Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soticlestat as Adjunctive Therapy in Lennox-Gastaut Syndrome
NCT04938427Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of soticlestat in Lennox-Gastaut syndrome (LGS), sponsored by Takeda. Started Nov 2021; status: completed.
02
Drugs
soticlestat
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT04938427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04938427.